Opaleye Management’s Evoke Pharma EVOK Stock Holding History

Opaleye Management’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-903	Closed	-$891K	–	47
2016 Q2	$891K	Hold	903	–	–	0.6%	45
2016 Q1	$662K	Hold	903	–	–	0.41%	46
2015 Q4	$429K	Sell	903 -903	-50%	-$459K	0.18%	52
2015 Q3	$757K	Buy	1,806 +7	+0.4%	+$4.4K	0.37%	43
2015 Q2	$1.35M	Buy	1,799 +98	+6%	+$83.4K	0.54%	39
2015 Q1	$1.73M	Buy	1,701 +34	+2%	+$30.7K	0.8%	31
2014 Q4	$1.42M	Sell	1,667 -187	-10%	-$154K	0.72%	33
2014 Q3	$1.47M	Buy	1,854 +170	+10%	+$164K	1.14%	26
2014 Q2	$1.96M	Buy	1,684 +63	+4%	+$72.4K	1.69%	17
2014 Q1	$1.96M	Buy	+1,621	New	+$2.31M	1.44%	20

Other funds holding EVOK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Opaleye Management's EVOK Position: Q3 2016 in Review

Opaleye Management sold out of Evoke Pharma (EVOK) in Q3 2016, closing a stake of 903 shares — an estimated $891K sold.

Opaleye Management first reported a position in EVOK in Q1 2014 and held it in 10 quarters. The position peaked at $1.96M in Q2 2014. 13 funds tracked by Wall St. Rank hold EVOK as of Q3 2016.

Opaleye Management reported no remaining Evoke Pharma position as of Q3 2016 after selling out during the quarter.
Opaleye Management sold 903 Evoke Pharma shares in Q3 2016, an estimated $891K.
Opaleye Management first reported a position in Evoke Pharma in Q1 2014 and held it in 10 quarters.
Opaleye Management's Evoke Pharma position peaked at $1.96M in Q2 2014.
13 funds tracked by Wall St. Rank held Evoke Pharma as of Q3 2016.

Based on Opaleye Management's 13F filing for Q3 2016, filed 14 Nov 2016.